Literature DB >> 9673546

Infective complications after abdominal surgery in patients infected with human immunodeficiency virus: role of CD4+ lymphocytes in prognosis.

C Emparan1, I M Iturburu, J Ortiz, J J Mendez.   

Abstract

Risk factors associated with surgical infections are related to many events that modulate the immune system and affect the surgical procedure. The aim of this study was to determine the influence of low CD4+ lymphocyte counts in 24 patients with human immunodeficiency virus (HIV) undergoing abdominal surgery. Blood samples were obtained, and the lymphocyte population was evaluated perioperatively, as was the nutritional status of the patient. All the patients received selective antibiotic prophylaxis depending on the surgical procedure performed: (1) clean surgery: splenectomies (n = 8); (2) clean-contaminated: cholecystectomy and biliary tract surgery (n = 8); and (3) contaminated: appendectomy (n = 8). Depending on their CD4 count, two groups were formed: one with 200 to 500 cells/ml (n = 11) and the other with < 200 cells/ml (n = 13). When surgical infection was suspected, surgical drainage and microbiologic cultures were undertaken. For statistical evaluation of the groups ANOVA and the chi-square test were used; p < 0.05 was considered significant. Altogether 14 patients (58.3%) had a wound infection, and the mean (+/- SD) CD4 count in those patients was decreased (221.7 +/- 75.1) compared with that of the 10 patients in the uneventful group (386 +/- 81.2). Surgical infection rates were 50% for clean procedures, 62.5% for clean-contaminated procedures, and 62.5% for contaminated surgery. The group of patients with CD4 counts of < 200 cell/ml had an increased incidence of surgical infection, regardless of the type of surgery (p = 0.002). Thus the surgical infection rates with HIV patients undergoing abdominal surgery are dramatically increased. The CD4 and subsequently depressed neutrophil populations increase the risk of surgical infection during major procedures regardless of the type of surgery performed.

Entities:  

Mesh:

Year:  1998        PMID: 9673546     DOI: 10.1007/s002689900469

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  CD4 Count is Still a Valid Indicator of Outcome in HIV-Infected Patients Undergoing Major Abdominal Surgery in the Era of Highly Active Antiretroviral Therapy.

Authors:  A Chichom-Mefire; M Azabji-Kenfack; J Atashili
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

2.  Radical prostatectomy in patients infected with human immunodeficiency virus.

Authors:  William C Huang; Eric O Kwon; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2006-08       Impact factor: 5.588

3.  The effect of stage of HIV disease as determined by CD4 count on clinical outcomes of surgical sepsis in South Africa.

Authors:  S Green; V Y Kong; G L Laing; J L Bruce; J Odendaal; B Sartorius; D L Clarke
Journal:  Ann R Coll Surg Engl       Date:  2017-07       Impact factor: 1.891

4.  Perioperative Antiretroviral Regimen for HIV/AIDS Patients Who Underwent Abdominal Surgery.

Authors:  Jing Yang; Guo Wei; Yong He; Xin Hua; Shifeng Feng; Yong Zhao; Tingyu Chen; Hua Wang; Liang Guo
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.282

Review 5.  Does HIV infection have an impact upon dental implant osseointegration? A systematic review.

Authors:  Javier Ata-Ali; Fadi Ata-Ali; Nicolas Di-Benedetto; Leticia Bagán; José-Vicente Bagán
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-05-01

6.  Anti-infective treatment in HIV-infected patients during perioperative period.

Authors:  Baochi Liu; Lei Zhang; Ruizhang Guo; Jinsong Su; Lei Li; Yanhui Si
Journal:  AIDS Res Ther       Date:  2012-11-27       Impact factor: 2.250

7.  Effect of emergency major abdominal surgery on CD4 cell count among HIV positive patients in a sub-Saharan Africa tertiary hospital--a prospective study.

Authors:  Gabriel Okumu; Patson Makobore; Sam Kaggwa; Andrew Kambugu; Moses Galukande
Journal:  BMC Surg       Date:  2013-02-26       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.